Assignee
NEXTGEN BIOSCIENCE CO LTD
KR·4 granted patents·0 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0162US12404252B2Salt of 2-amino-2-(2-(1-decyl-1H-1,2,3-triazol-4-yl)ethyl)propane-1,3-diol, and pharmaceutical composition containing sameNEXTGEN BIOSCIENCE CO LTD·Filed 2022·Granted Sep 2, 2025·0 cites·8 claims
- 0260US11957665B1Pharmaceutical composition for preventing or treating alopecia areata acting as a functional antagonist for S1PR1 and S1PR4NEXTGEN BIOSCIENCE CO LTD·Filed 2023·Granted Apr 16, 2024·0 cites·10 claims
- 0359US12048689B2Pharmaceutical composition for preventing or treating inflammatory bowel disease acting as a functional antagonist for S1PR1 and S1PR4NEXTGEN BIOSCIENCE CO LTD·Filed 2023·Granted Jul 30, 2024·0 cites·6 claims
- 0454US12145929B2Piperidine derivative and pharmaceutical composition for inhibiting autotaxin comprising sameNEXTGEN BIOSCIENCE CO LTD·Filed 2022·Granted Nov 19, 2024·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when NEXTGEN BIOSCIENCE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →